HY26 · Released 21 November 2025
PBT scrapes to NZ$1.0m as tax benefit lifts NPAT and capex doubles
Headline swing to profit masks a barely-breakeven pre-tax result, an NZ$8.4m free cash outflow, and leverage still at 14.5x EBITDA.
OCA · NZX
Oceania Healthcare is an NZX-listed retirement living company covered by Annolyse across HY26. This page brings together the latest briefing, the current metrics snapshot, and the published history to date in one place.
Snapshot
HY26, released 21 November 2025
| Metric | Value |
|---|---|
| Revenue | $131.6m |
| EBITDA | $41.5m |
| NPAT | $4.9m |
| Operating cash flow | $79.0m |
| OCF / EBITDA % | 190.4% |
| Net debt | $601.5m |
| Net debt / EBITDA | 14.50x |
| ROE % | 0.4% |
| PBT | $1.0m |
| FCF pre-lease | -$8.4m |
Longitudinal view
Current-period values from each published briefing, with the most recent reporting period shown first.
| Metric | HY266 MONTHS21 November 2025 |
|---|---|
| Revenue | $131.6m |
| Revenue growth % | -0.7% |
| EBITDA | $41.5m |
| EBITDA margin % | 31.5% |
| PBT | $1.0m |
| NPAT | $4.9m |
| Operating cash flow | $79.0m |
| OCF / EBITDA % | 190.4% |
| FCF pre-lease | -$8.4m |
| FCF post-lease | -$8.4m |
| ROE % | 0.4% |
| Net debt | $601.5m |
| Net debt / EBITDA | 14.50x |
| Debtor days | 29 |
| Total assets | $3037.6m |
Source: annolyse.ai/companies/oca
Accountability
Read the prior briefing's expectations and unresolved questions alongside the subsequent result, without forcing long-form editorial text into narrow cards.
Once a second briefing exists for this company, this section will compare the previous briefing's expectations and unresolved issues with what actually happened in the next result.
Archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
Subscribe
Subscribe to get future Annolyse briefings as soon as they are published.